Skip Navigation LinksHome > August 2008 - Volume 27 - Issue 8 > Treatment of Central Venous Catheter Fungal Infection Using...
Pediatric Infectious Disease Journal:
doi: 10.1097/INF.0b013e318170b68b
Brief Reports

Treatment of Central Venous Catheter Fungal Infection Using Liposomal Amphotericin-B Lock Therapy

Buckler, Bradley S. MD*; Sams, Ralph N. BS†; Goei, Vita L. MD*; Krishnan, Karthik R. MD*; Bemis, Marci J. PharmD‡; Parker, Deidrea P. RPh‡; Murray, Dennis L. MD*

Collapse Box

Abstract

The current standard of care for a fungal central venous catheter infection in a pediatric patient usually requires removal without any other feasible options. Although removal may reduce the rate of Candida-associated complications, literature reviews question whether the outcomes of removal substantiate this being the standard of care. We report 6 cases of central venous catheter fungal infections treated with liposomal amphotericin-B lock therapy. These cases consisted of 4 patients, 2 of whom received recurrent therapy. In 4 of these cases, there was successful eradication of the infectious fungal agent, allowing continued use of the catheter. A controlled study of antifungal lock therapy should be considered as a potential alternative to removal.

© 2008 Lippincott Williams & Wilkins, Inc.

Login

Article Tools

Share

Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.